TH1601000099A - Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation. - Google Patents

Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation.

Info

Publication number
TH1601000099A
TH1601000099A TH1601000099A TH1601000099A TH1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A
Authority
TH
Thailand
Prior art keywords
anticholinergic
corticosteroid
adrenergic
inhalation
beta
Prior art date
Application number
TH1601000099A
Other languages
Thai (th)
Other versions
TH159392B (en
TH159392A (en
Inventor
มูซ่านางสาวไอรีน ปาสควาลีนายอะซิต้า อัสกี้ ซาร์วาร์นายฟรานเซลก้า เชียร์เรตตี นายรอสเซลล่า
Original Assignee
กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ
Filing date
Publication date
Application filed by กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ filed Critical กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ
Publication of TH159392B publication Critical patent/TH159392B/en
Publication of TH1601000099A publication Critical patent/TH1601000099A/en
Publication of TH159392A publication Critical patent/TH159392A/th

Links

TH1601000099A 2014-07-10 Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation. TH1601000099A (en)

Publications (3)

Publication Number Publication Date
TH159392B TH159392B (en) 2017-01-18
TH1601000099A true TH1601000099A (en) 2017-01-18
TH159392A TH159392A (en) 2017-01-18

Family

ID=

Similar Documents

Publication Publication Date Title
IL273507A (en) Methods, devices and systems for pulmonary delivery of active agents
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
DK3332767T3 (en) Liquid inhalation formulation comprising RPL554
DK3569222T3 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
DK3107548T3 (en) DRY POWDER FORMULATIONS FOR INHALATION
DK3325059T3 (en) DRY POWDER INHALATOR
DK3505209T3 (en) POWDER INHALATOR
SG11201608943VA (en) Substituted 4-phenylpiperidines, their preparaiton and use
ZA201902762B (en) Mission-critical push-to-talk
DK3620176T3 (en) A process for the preparation of a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
DK3129006T3 (en) Immunosuppressive formulation
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
DK3138600T3 (en) The dry powder inhaler
DK3689379T3 (en) A process for the preparation of a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
PL3040062T3 (en) Absorbent structure, and absorbent item comprising this absorbent structure
PL3256154T3 (en) Pharmaceutical formulation comprising antibody
DK3179986T3 (en) DRY POWDER FORMULATIONS FOR INHALATION
IL249773A0 (en) Dry powder medicament de-agglomerator
BR112016025075A2 (en) agrochemical formulation.
SG11201700276QA (en) Quinoxaline compounds, method for preparing the same and use thereof
DK2915526T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
GB201409603D0 (en) An inhalable medicament
FR3021118B1 (en) SUPERCONDUCTING COMPONENT, AMPLIFIER
TH1601000099A (en) Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation.
DK3212212T3 (en) POWDER FORMULATION